Berardinelli-seip congenital lipodystrophy 2/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation

Weiqin Chen, Benny Chang, Pradip Saha, Sean M. Hartig, Lan Li, Vasumathi Theegala Reddy, Yisheng Yang, Vijay Yechoor, Michael A. Mancini, Lawrence Chan

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Mutations in BSCL2 underlie human congenital generalized lipodystrophy. We inactivated Bscl2 in mice to examine the mechanisms whereby absence of Bscl2 leads to adipose tissue loss and metabolic disorders. Bscl2 -/- mice develop severe lipodystrophy of white adipose tissue (WAT), dyslipidemia, insulin resistance, and hepatic steatosis. In vitro differentiation of both Bscl2 -/- murine embryonic fibroblasts (MEFs) and stromal vascular cells (SVCs) reveals normal early-phase adipocyte differentiation but a striking failure in terminal differentiation due to unbridled cyclic AMP (cAMP)-dependent protein kinase A (PKA)-activated lipolysis, which leads to loss of lipid droplets and silencing of the expression of adipose tissue-specific transcription factors. Importantly, such defects in differentiation can be largely rescued by inhibitors of lipolysis but not by a gamma peroxisome proliferator-activated receptor (PPARγ) agonist. The residual epididymal WAT (EWAT) in Bscl2 -/- mice displays enhanced lipolysis. It also assumes a "brown-like" phenotype with marked upregulation of UCP1 and other brown adipose tissue-specific markers. Together with decreased Pref1 but increased C/EBPβ levels, these changes highlight a possible increase in cAMP signaling that impairs terminal adipocyte differentiation in the EWAT of Bscl2 -/- mice. Our study underscores the fundamental role of regulated cAMP/PKA-mediated lipolysis in adipose differentiation and identifies Bscl2 as a novel cell-autonomous determinant of activated lipolysis essential for terminal adipocyte differentiation.

Original languageEnglish (US)
Pages (from-to)1099-1111
Number of pages13
JournalMolecular and Cellular Biology
Volume32
Issue number6
DOIs
StatePublished - Mar 1 2012

Fingerprint

Congenital Generalized Lipodystrophy
Lipolysis
Adipocytes
Cyclic AMP-Dependent Protein Kinases
White Adipose Tissue
Cyclic AMP
Adipose Tissue
Lipodystrophy
Adenylate Kinase
Brown Adipose Tissue
PPAR gamma
Stromal Cells
Dyslipidemias
Blood Vessels
Insulin Resistance
Transcription Factors
Up-Regulation
Fibroblasts
Phenotype
Mutation

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Berardinelli-seip congenital lipodystrophy 2/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation. / Chen, Weiqin; Chang, Benny; Saha, Pradip; Hartig, Sean M.; Li, Lan; Reddy, Vasumathi Theegala; Yang, Yisheng; Yechoor, Vijay; Mancini, Michael A.; Chan, Lawrence.

In: Molecular and Cellular Biology, Vol. 32, No. 6, 01.03.2012, p. 1099-1111.

Research output: Contribution to journalArticle

Chen, Weiqin ; Chang, Benny ; Saha, Pradip ; Hartig, Sean M. ; Li, Lan ; Reddy, Vasumathi Theegala ; Yang, Yisheng ; Yechoor, Vijay ; Mancini, Michael A. ; Chan, Lawrence. / Berardinelli-seip congenital lipodystrophy 2/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation. In: Molecular and Cellular Biology. 2012 ; Vol. 32, No. 6. pp. 1099-1111.
@article{653abbfb5359410f8def1af300a13058,
title = "Berardinelli-seip congenital lipodystrophy 2/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation",
abstract = "Mutations in BSCL2 underlie human congenital generalized lipodystrophy. We inactivated Bscl2 in mice to examine the mechanisms whereby absence of Bscl2 leads to adipose tissue loss and metabolic disorders. Bscl2 -/- mice develop severe lipodystrophy of white adipose tissue (WAT), dyslipidemia, insulin resistance, and hepatic steatosis. In vitro differentiation of both Bscl2 -/- murine embryonic fibroblasts (MEFs) and stromal vascular cells (SVCs) reveals normal early-phase adipocyte differentiation but a striking failure in terminal differentiation due to unbridled cyclic AMP (cAMP)-dependent protein kinase A (PKA)-activated lipolysis, which leads to loss of lipid droplets and silencing of the expression of adipose tissue-specific transcription factors. Importantly, such defects in differentiation can be largely rescued by inhibitors of lipolysis but not by a gamma peroxisome proliferator-activated receptor (PPARγ) agonist. The residual epididymal WAT (EWAT) in Bscl2 -/- mice displays enhanced lipolysis. It also assumes a {"}brown-like{"} phenotype with marked upregulation of UCP1 and other brown adipose tissue-specific markers. Together with decreased Pref1 but increased C/EBPβ levels, these changes highlight a possible increase in cAMP signaling that impairs terminal adipocyte differentiation in the EWAT of Bscl2 -/- mice. Our study underscores the fundamental role of regulated cAMP/PKA-mediated lipolysis in adipose differentiation and identifies Bscl2 as a novel cell-autonomous determinant of activated lipolysis essential for terminal adipocyte differentiation.",
author = "Weiqin Chen and Benny Chang and Pradip Saha and Hartig, {Sean M.} and Lan Li and Reddy, {Vasumathi Theegala} and Yisheng Yang and Vijay Yechoor and Mancini, {Michael A.} and Lawrence Chan",
year = "2012",
month = "3",
day = "1",
doi = "10.1128/MCB.06465-11",
language = "English (US)",
volume = "32",
pages = "1099--1111",
journal = "Molecular and Cellular Biology",
issn = "0270-7306",
publisher = "American Society for Microbiology",
number = "6",

}

TY - JOUR

T1 - Berardinelli-seip congenital lipodystrophy 2/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation

AU - Chen, Weiqin

AU - Chang, Benny

AU - Saha, Pradip

AU - Hartig, Sean M.

AU - Li, Lan

AU - Reddy, Vasumathi Theegala

AU - Yang, Yisheng

AU - Yechoor, Vijay

AU - Mancini, Michael A.

AU - Chan, Lawrence

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Mutations in BSCL2 underlie human congenital generalized lipodystrophy. We inactivated Bscl2 in mice to examine the mechanisms whereby absence of Bscl2 leads to adipose tissue loss and metabolic disorders. Bscl2 -/- mice develop severe lipodystrophy of white adipose tissue (WAT), dyslipidemia, insulin resistance, and hepatic steatosis. In vitro differentiation of both Bscl2 -/- murine embryonic fibroblasts (MEFs) and stromal vascular cells (SVCs) reveals normal early-phase adipocyte differentiation but a striking failure in terminal differentiation due to unbridled cyclic AMP (cAMP)-dependent protein kinase A (PKA)-activated lipolysis, which leads to loss of lipid droplets and silencing of the expression of adipose tissue-specific transcription factors. Importantly, such defects in differentiation can be largely rescued by inhibitors of lipolysis but not by a gamma peroxisome proliferator-activated receptor (PPARγ) agonist. The residual epididymal WAT (EWAT) in Bscl2 -/- mice displays enhanced lipolysis. It also assumes a "brown-like" phenotype with marked upregulation of UCP1 and other brown adipose tissue-specific markers. Together with decreased Pref1 but increased C/EBPβ levels, these changes highlight a possible increase in cAMP signaling that impairs terminal adipocyte differentiation in the EWAT of Bscl2 -/- mice. Our study underscores the fundamental role of regulated cAMP/PKA-mediated lipolysis in adipose differentiation and identifies Bscl2 as a novel cell-autonomous determinant of activated lipolysis essential for terminal adipocyte differentiation.

AB - Mutations in BSCL2 underlie human congenital generalized lipodystrophy. We inactivated Bscl2 in mice to examine the mechanisms whereby absence of Bscl2 leads to adipose tissue loss and metabolic disorders. Bscl2 -/- mice develop severe lipodystrophy of white adipose tissue (WAT), dyslipidemia, insulin resistance, and hepatic steatosis. In vitro differentiation of both Bscl2 -/- murine embryonic fibroblasts (MEFs) and stromal vascular cells (SVCs) reveals normal early-phase adipocyte differentiation but a striking failure in terminal differentiation due to unbridled cyclic AMP (cAMP)-dependent protein kinase A (PKA)-activated lipolysis, which leads to loss of lipid droplets and silencing of the expression of adipose tissue-specific transcription factors. Importantly, such defects in differentiation can be largely rescued by inhibitors of lipolysis but not by a gamma peroxisome proliferator-activated receptor (PPARγ) agonist. The residual epididymal WAT (EWAT) in Bscl2 -/- mice displays enhanced lipolysis. It also assumes a "brown-like" phenotype with marked upregulation of UCP1 and other brown adipose tissue-specific markers. Together with decreased Pref1 but increased C/EBPβ levels, these changes highlight a possible increase in cAMP signaling that impairs terminal adipocyte differentiation in the EWAT of Bscl2 -/- mice. Our study underscores the fundamental role of regulated cAMP/PKA-mediated lipolysis in adipose differentiation and identifies Bscl2 as a novel cell-autonomous determinant of activated lipolysis essential for terminal adipocyte differentiation.

UR - http://www.scopus.com/inward/record.url?scp=84863245021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863245021&partnerID=8YFLogxK

U2 - 10.1128/MCB.06465-11

DO - 10.1128/MCB.06465-11

M3 - Article

C2 - 22269949

AN - SCOPUS:84863245021

VL - 32

SP - 1099

EP - 1111

JO - Molecular and Cellular Biology

JF - Molecular and Cellular Biology

SN - 0270-7306

IS - 6

ER -